Triple-Negative Breast Cancer: Tumor Immunogenicity and Beyond

Triple-Negative Breast Cancer: Tumor Immunogenicity and Beyond

Blog Article

Triple-negative breast cancer (TNBC) is a breast malignancy with a poor prognosis and limited therapeutic options.Many studies show that TNBC exhibits heterogeneity across clinical, histopathological, and molecular levels.In this review, usc trojans snapback hat we discuss the immunogenic features of TNBC with a focus on immunotherapy and the current standard of care in the bekindtopets.com neoadjuvant, adjuvant, and metastatic setting.In addition, we address the ongoing research on immunotherapy, antibody-drug conjugates (ADCs), poly ADP-ribose polymerase (PARP) inhibitors, and future challenges in the treatment of this entity.